Sangamo Therapeutics
SGMO
#10512
Rank
NZ$36.64 M
Marketcap
NZ$0.08845
Share price
0.00%
Change (1 day)
-90.07%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.78. In 2024 the company made an earnings per share (EPS) of NZ-$0.90.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-15.43%
2024NZ-$0.90
2022NZ-$2.210.81%
2021NZ-$2.1933.33%
2020NZ-$1.656.9%
2019NZ-$1.5422.54%
2018NZ-$1.261.43%
2017NZ-$1.24-31.37%
2016NZ-$1.8075.86%
2015NZ-$1.0348.72%
2014NZ-$0.69-17.02%
2013NZ-$0.839.3%
2012NZ-$0.76-39.44%
2011NZ-$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.46-2,085.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.62-3,390.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.54-2,225.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$7.06 806.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.12-1,656.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.29-908.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.70-961.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.48-418.18%๐Ÿ‡บ๐Ÿ‡ธ USA